 Cystadenoma
"Cystadenoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed)
| Descriptor ID |
D003537
|
| MeSH Number(s) |
C04.557.470.035.320 C04.557.470.590.485
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cystadenoma".
Below are MeSH descriptors whose meaning is more specific than "Cystadenoma".
This graph shows the total number of publications written about "Cystadenoma" by people in Harvard Catalyst Profiles by year, and whether "Cystadenoma" was a major or minor topic of these publication.
Below are the most recent publications written about "Cystadenoma" by people in Profiles.
-
Dewhurst CE, Mortele KJ. Cystic tumors of the pancreas: imaging and management. Radiol Clin North Am. 2012 May; 50(3):467-86.
-
Ishikawa H, Kiyokawa T, Takatani T, Wen WG, Shozu M. Giant multilocular sex cord tumor with annular tubules associated with precocious puberty. Am J Obstet Gynecol. 2012 Jan; 206(1):e14-6.
-
Marchegiani G, Crippa S, Malleo G, Partelli S, Capelli P, Pederzoli P, Falconi M. Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. Pancreatology. 2011; 11(4):383-9.
-
Worley MJ, Landen CN, Slomovitz BM, Malpica A, Palla SL, Ramirez PT. Expression of the retinoblastoma-related gene Rb2/p130 in the pathogenesis of serous carcinoma of the ovary. Appl Immunohistochem Mol Morphol. 2010 Dec; 18(6):509-11.
-
Jakobiec FA, Bhat P, Kropp TM. Palpebro-orbital apocrine cystadenoma: immunohistochemical verification of a unique variant with a critical differential diagnosis. Ophthal Plast Reconstr Surg. 2010 Jul-Aug; 26(4):245-9.
-
Woodrum C, Nobil A, Dabora SL. Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors. J Transl Med. 2010; 8:14.
-
Finlay GA, Malhowski AJ, Polizzi K, Malinowska-Kolodziej I, Kwiatkowski DJ. Renal and liver tumors in Tsc2(+/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Mol Cancer Ther. 2009 Jul; 8(7):1799-807.
-
Lee N, Woodrum CL, Nobil AM, Rauktys AE, Messina MP, Dabora SL. Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models. BMC Pharmacol. 2009; 9:8.
-
Sugiyama A, Sugiura M, Piris A, Tomita Y, Mihm MC. Apocrine cystadenoma and apocrine hidrocystoma: examination of 21 cases with emphasis on nomenclature according to proliferative features. J Cutan Pathol. 2007 Dec; 34(12):912-7.
-
Sidden CR, Mortele KJ. Cystic tumors of the pancreas: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MR. 2007 Oct; 28(5):339-56.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|